The FY2025 (Dec) proxy of Biocryst Pharmaceuticals names 18 peer companies for pay. Pay versus performance data of Biocryst Pharmaceuticals for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| PTC Therapeutics | ||
| INSMED | ||
| Ultragenyx Pharmaceutical | ||
| Mirum Pharmaceuticals | ||
| Adma Biologics | ||
| Travere Therapeutics | ||
| Harmony Biosciences Holdings | ||
| Acadia Pharmaceuticals | Not disclosed | Not disclosed |
| Amicus Therapeutics | Not disclosed | Not disclosed |
| Apellis Pharmaceuticals | Not disclosed | Not disclosed |
| Ardelyx | Not disclosed | Not disclosed |
| Arrowhead Pharmaceuticals | Not disclosed | Not disclosed |
| Catalyst Pharmaceuticals | Not disclosed | Not disclosed |
| Corcept Therapeutics | Not disclosed | Not disclosed |
| Dynavax Technologies | Not disclosed | Not disclosed |
| Pacira BioSciences | Not disclosed | Not disclosed |
| Rhythm Pharmaceuticals | Not disclosed | Not disclosed |
| SIGA Technologies | Not disclosed | Not disclosed |
18 companies
Changes by year
FY2025 (Dec) proxy
- AddedArdelyxpay peer groupto reflect changes in the Company’s market capitalization and revenue during 2025, which resulted in the removal of Agenus and Ironwood Pharmaceuticals
- AddedCatalyst Pharmaceuticalspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2025, which resulted in the removal of Agenus and Ironwood Pharmaceuticals
- AddedMirum Pharmaceuticalspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2025, which resulted in the removal of Agenus and Ironwood Pharmaceuticals
- AddedRhythm Pharmaceuticalspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2025, which resulted in the removal of Agenus and Ironwood Pharmaceuticals
- RemovedAgenuspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2025, which resulted in the removal of Agenus and Ironwood Pharmaceuticals
- RemovedIronwood Pharmaceuticalspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2024, which resulted in the removal of Cytokinetics and MacroGenics
FY2024 (Dec) proxy
- AddedIronwood Pharmaceuticalspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2024, which resulted in the removal of Cytokinetics and MacroGenics
- AddedPacira BioSciencespay peer groupto reflect changes in the Company’s market capitalization and revenue during 2024, which resulted in the removal of Cytokinetics and MacroGenics
- RemovedMacroGenicspay peer groupto reflect changes in the Company’s market capitalization and revenue during 2024, which resulted in the removal of Cytokinetics and MacroGenics
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.